Active, Not Recruiting
A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm
NCT04041050
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +22 more
- Locations
-
- City of Hope /ID# 239769 Duarte, California, United States
- Providence - St. Jude Medical Center /ID# 242558 Fullerton, California, United States
- Moores Cancer Center at UC San Diego /ID# 229584 La Jolla, California, United States
- UCLA /Id# 222784 Los Angeles, California, United States